Update on GVKBio-Quantitative Solutions Clinical Outcomes Databases

Dear All GVK Bio and Quantitative solutions are pleased to announce that the no of modeler ready Clinical Outcomes Databases has increased to eight indications. The databases available include: i. RA ii. Pain iii. Depression iv. Osteoporosis v. HCV vi. Alzheimer's vii. Schizophrenia viii. Dyslipidemia Additional indications are in the development phase. Regards Sreeni Sreeni Devidas Ph.D. Vice President Business Development GVK BioSciences 5457 Twin Knolls Road Suite 101 Columbia, MD 21045 Tel: 443-838-6260 Fax: (703) 940 4088 www.gvkbio.com http://www.gvkbio.com/ Notice: The information contained in this electronic mail message is intended only for the use of the designated recipient. This message is privileged and confidential. and the property of GVK BIO or its affiliates and subsidiaries. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone +91-40-66929999 and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies).